This federal contract award, valued at $3,940.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Testosterone Cypionate 200 mg/mL medication, a firm fixed price delivery order with an ultimate completion date of April 12, 2024.
Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract award does not have a set-aside designation.
Generated 7/11/24, 9:53 AM